Ҵý

Feature Channels: Vision

Filters close
Go to Advanced Search
Released: 3-May-2025 4:00 PM EDT
Facing the Future: Combating Vision Loss in the Diabetes Epidemic
Association for Research in Vision and Ophthalmology (ARVO)

Salt Lake City, Utah — Diabetes is a major health crisis in the U.S. that not only bears a heavy economic burden but increases the risk of severe health complications, including blindness. From May 4 - 8 in Salt Lake City, Utah, scientists will unveil new findings on various diabetes-related eye complications at the 2025 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO).

Released: 3-May-2025 12:00 PM EDT
Biological Insights and Social Impact in Eye Health to Feature at ARVO 2025 Annual Meeting
Association for Research in Vision and Ophthalmology (ARVO)

Salt Lake City, Utah — Your eyes are more than windows to the soul, they are windows to your overall health. This message will resonate throughout the upcoming week (May 4 - 8) at the 2025 Annual Meeting of the Association for Research in Vision and Ophthalmology in in Salt Lake City, Utah. Here scientists will present new data on critical connections between vision research and public health, illustrating how each informs and strengthens the other.

Released: 2-May-2025 9:10 PM EDT
Harnessing Artificial Intelligence to Transform Vision Research
Association for Research in Vision and Ophthalmology (ARVO)

Salt Lake City, Utah — Artificial Intelligence (AI) is reshaping the way we comprehend, detect and treat eye conditions, bringing new hope to millions worldwide. During the upcoming week (May 4 - 8) at the 2025 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Salt Lake City, Utah, researchers will share breakthroughs on how AI is influencing the future of eye and vision health research and patient care, from enhancing clinical decision-making to simplifying workflows to equip patients with educational tools to create personalized care plans.

Ҵý: JMIR Rehabilitation and Assistive Technologies Invites Submissions on Advancing Telerehabilitation Research and Innovation
Released: 1-May-2025 9:45 AM EDT
JMIR Rehabilitation and Assistive Technologies Invites Submissions on Advancing Telerehabilitation Research and Innovation
JMIR Publications

JMIR Publications invites submissions to a new theme issue titled “The Importance of Telerehabilitation and Future Directions for the Field” in its open access journal JMIR Rehabilitation and Assistive Technologies.

Released: 1-May-2025 8:05 AM EDT
The Silent Thief of Sight: New Hope in Glaucoma Research
Association for Research in Vision and Ophthalmology (ARVO)

Salt Lake City, Utah — Glaucoma continues to be a public health challenge that affects around 4.22 million Americans and remains the leading cause of irreversible blindness in the U.S. Often called the “silent thief of sight”, glaucoma is a group of eye diseases that damages the optic nerve, the vital link between the eyes and brain.

Released: 1-May-2025 8:00 AM EDT
Revolutionizing Myopia Treatments Among Highlights at Upcoming ARVO 2025 Annual Meeting
Association for Research in Vision and Ophthalmology (ARVO)

Salt Lake City, Utah — If you or someone you know has trouble seeing things far away, you most likely have nearsightedness, also known as myopia. It is a common eye problem which, if not managed, can lead to serious issues like glaucoma, vision loss or blindness. The number of people with myopia is on the rise, with experts predicting that nearly half the world could be myopic by 2050.

Released: 30-Apr-2025 7:15 PM EDT
Dr. Alon Harris Winner of the Glaucoma Foundation’s 2025 Robert Ritch Award
The Glaucoma Foundation

Alon Harris, MS, PhD, FARVO, has been named the 2025 recipient of The Glaucoma Foundation’s (TGF) Robert Ritch Award for Innovation and Excellence in Glaucoma.

Released: 30-Apr-2025 7:00 PM EDT
2025 ARVO Annual Meeting to Showcase Groundbreaking Research in Age-Related Macular Degeneration
Association for Research in Vision and Ophthalmology (ARVO)

Transformative research offering fresh insights and treatment advancements for age-related macular degeneration (AMD), the leading cause of blindness in adults over age 50, will be among the highlights showcased from May 4 - 8 at the Association for Research in Vision and Ophthalmology’s (ARVO) 2025 Annual Meeting in Salt Lake City, Utah.

Released: 30-Apr-2025 7:00 PM EDT
From Lab to Sight: How New Retina Research Is Changing Lives
Association for Research in Vision and Ophthalmology (ARVO)

From May 4 - 8, more than 8,000 scientists will gather at the Association for Research in Vision and Ophthalmology’s (ARVO) 2025 Annual Meeting in Salt Lake City, Utah, to share the latest discoveries in eye and vision research. Many studies being presented focus on the retina, the light-sensitive tissue at the back of the eye that captures the images people see and sends signals to the brain so that people can see and understand the world around them.

Released: 29-Apr-2025 8:35 AM EDT
Tavo Biotherapeutics Announces Appointment of Seasoned Executives to Key Posts
Tavo Biotherapeutics

---- Lukas Scheibler, Ph.D. to become Chief Research and Development Officer and Graham Cooper to become Chief Financial Officer ---- Additions to senior team will drive Tavo's strategy to develop new innovative therapeutics addressing critical unmet needs in glaucoma and retinal disease

   
Released: 26-Apr-2025 12:00 PM EDT
Evaluating the Efficacy of Stem Cells in Treating Severe Dry Eye Disease
World Journal of Stem Cells

Dry eye disease (DED) is a multifactorial disorder that disturbs ocular surface equilibrium, considerably diminishing quality of life. Present therapies only offer symptomatic alleviation. Stem cell treatment, especially mesenchymal stem ce

Released: 23-Apr-2025 6:35 PM EDT
For Eye Infections, Delayed Doctor Visits and Extent of Damage Affect Vision Outcomes
Michigan Medicine - University of Michigan

In a study published in Ophthalmology, physicians followed 562 patients in the United States and India over a three-month period to identify risk factors that could be easily managed with early intervention.

Ҵý: Study Reveals Key Roles in Developmental Milestones of the Brain in Children
Released: 23-Apr-2025 5:05 PM EDT
Study Reveals Key Roles in Developmental Milestones of the Brain in Children
University of North Carolina School of Medicine

Led by UNC School of Medicine’s Weili Lin, PhD, researchers document cognitive milestones revealed in children from birth to toddlerhood in brain imaging study.

Released: 14-Apr-2025 5:35 PM EDT
UF Professor Develops AI Tool to Better Assess Parkinson’s Disease, Other Movement Disorders
University of Florida

A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders. The tool, called VisionMD, helps doctors more accurately monitor subtle motor changes, improving patient care and advancing clinical research.

Released: 10-Apr-2025 8:20 PM EDT
Moffitt-Led International Study Finds New Drug Delivery System Effective Against Rare Eye Cancer
Moffitt Cancer Center

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver. This disease, known as metastatic uveal melanoma, is traditionally very hard to treat and usually has poor outcomes.

Ҵý: Neonatal Diabetes Model Provides Insights on How Condition Develops
Released: 8-Apr-2025 7:10 PM EDT
Neonatal Diabetes Model Provides Insights on How Condition Develops
UT Southwestern Medical Center

A preclinical model developed at UT Southwestern Medical Center that recapitulates a rare infant-onset form of diabetes suggests the condition stems from gradual damage to the pancreas through misregulation of a molecular pathway called the unfolded protein response (UPR). The findings, published in Molecular Metabolism, could one day lead to new ways to treat more common subsets of diabetes, including Types 1 and 2, which affect hundreds of millions worldwide.

Ҵý:Video Embedded curious-by-nature-dr-gilbert-bernier-can-stem-cells-cure-blindness
VIDEO
Released: 4-Apr-2025 5:50 PM EDT
Curious by Nature: Dr. Gilbert Bernier - Can Stem Cells Cure Blindness?
News

Dr. Gilbert Bernier, a neuroscientist and professor at the University of Montreal who is pushing the boundaries of regenerative medicine.

Ҵý: Australian Public Libraries Failing Readers with Print Disabilities
Released: 2-Apr-2025 12:00 PM EDT
Australian Public Libraries Failing Readers with Print Disabilities
University of South Australia

A new study has revealed that Australia’s public libraries are struggling to adequately support people with print disabilities, leaving a significant portion of the population without access ...



close
2.26799